No Yes Ok

Archive

« Older Entries Newer Entries »

Immunic, Inc. Appoints Industry Veteran Tamara A. Seymour as Interim Chief Financial Officer Monday, April 29th, 2019
SAN DIEGO, April 29, 2019 – Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune disea [...]
The French Région Sud and the European Union provide grant funding to Imcheck Therapeutics and its development of a new generation of cancer treatments Tuesday, April 23rd, 2019
Through a 717 K€ grant co-financed by the Région Sud and the European Union under the ERDF, ImCheck has received non-dilutive funding for its translational research platform   Marseille, France, 23 April 201 [...]
LSP Life Sciences Fund Performing strongly and ending Q1 2019 up +17.5% Thursday, April 18th, 2019
For more insight into our returns and investment strategy please read our just published March Monthly LSP Life Sciences Fund report. To see the full report click here.  [...]
Upcoming Event: Biotech update 2019 Friday, April 12th, 2019
Biotech Update 2019 Wednesday 26th June, 2019 Kasteel De Wittenburg in Wassenaar, The Netherlands [...]
Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases Friday, April 12th, 2019
Developing Oral Therapies with Best-in-Class Potential Lead Program, IMU-838, Already Advanced into Phase 2 Studies in Ulcerative Colitis and Relapsing-Remitting Multiple Sclerosis Proceeds of approxim [...]
Probiodrug raises EUR 8.2 million from investors in successful private placement of new shares Tuesday, April 9th, 2019
Capital increase of its share capital by issuing 4,093,367 new shares at a purchase price of EUR 2 per new share Consortium of strategic investors led by Claus Christiansen, founder and chairman of Nordic Bi [...]
Merus Announces Financial Results for the Full Year 2018 and Provides Business Update Thursday, April 4th, 2019
Multiple Updates from Biclonics® Clinical Trials Expected in 2019   UTRECHT, The Netherlands, April 03, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company [...]
Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019 Monday, April 1st, 2019
CD137 and PD-L1 bispecific antibody with context-dependent T cell activation   UTRECHT, Netherlands, April 01, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Co [...]
Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero Tuesday, March 26th, 2019
Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero  Menarini Diagnostics to distribute Unyvero Platform and application cartrid [...]
Probiodrug and Alzheimer’s Disease Cooperative Study (ADCS) Receive 15 Million USD National Institutes of Health (NIH) Grant for U.S. Phase 2b Core Progr... Wednesday, March 20th, 2019
HALLE (SAALE), Germany and San Diego, CA – USA, 20 March 2019 – Probiodrug AG, a clinical stage biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD) (Euronext Amster [...]

« Older Entries Newer Entries »

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
Follow us

No Yes Ok

Archive

« Older Entries Newer Entries »

Immunic, Inc. Appoints Industry Veteran Tamara A. Seymour as Interim Chief Financial Officer Monday, April 29th, 2019
SAN DIEGO, April 29, 2019 – Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune disea [...]
The French Région Sud and the European Union provide grant funding to Imcheck Therapeutics and its development of a new generation of cancer treatments Tuesday, April 23rd, 2019
Through a 717 K€ grant co-financed by the Région Sud and the European Union under the ERDF, ImCheck has received non-dilutive funding for its translational research platform   Marseille, France, 23 April 201 [...]
LSP Life Sciences Fund Performing strongly and ending Q1 2019 up +17.5% Thursday, April 18th, 2019
For more insight into our returns and investment strategy please read our just published March Monthly LSP Life Sciences Fund report. To see the full report click here.  [...]
Upcoming Event: Biotech update 2019 Friday, April 12th, 2019
Biotech Update 2019 Wednesday 26th June, 2019 Kasteel De Wittenburg in Wassenaar, The Netherlands [...]
Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases Friday, April 12th, 2019
Developing Oral Therapies with Best-in-Class Potential Lead Program, IMU-838, Already Advanced into Phase 2 Studies in Ulcerative Colitis and Relapsing-Remitting Multiple Sclerosis Proceeds of approxim [...]
Probiodrug raises EUR 8.2 million from investors in successful private placement of new shares Tuesday, April 9th, 2019
Capital increase of its share capital by issuing 4,093,367 new shares at a purchase price of EUR 2 per new share Consortium of strategic investors led by Claus Christiansen, founder and chairman of Nordic Bi [...]
Merus Announces Financial Results for the Full Year 2018 and Provides Business Update Thursday, April 4th, 2019
Multiple Updates from Biclonics® Clinical Trials Expected in 2019   UTRECHT, The Netherlands, April 03, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company [...]
Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019 Monday, April 1st, 2019
CD137 and PD-L1 bispecific antibody with context-dependent T cell activation   UTRECHT, Netherlands, April 01, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Co [...]
Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero Tuesday, March 26th, 2019
Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero  Menarini Diagnostics to distribute Unyvero Platform and application cartrid [...]
Probiodrug and Alzheimer’s Disease Cooperative Study (ADCS) Receive 15 Million USD National Institutes of Health (NIH) Grant for U.S. Phase 2b Core Pro... Wednesday, March 20th, 2019
HALLE (SAALE), Germany and San Diego, CA – USA, 20 March 2019 – Probiodrug AG, a clinical stage biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD) (Euronext Amster [...]

« Older Entries Newer Entries »

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
X

MONTHLY REPORTS

Here you can subscribe for the monthly report of the LSP Life Sciences Fund